1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31
Louise Saul,Iris Mair,Alasdair Ivens,Pamela Brown,Kay Samuel,John D. M. Campbell,Daniel Y. Soong,Nadine Kamenjarin,Richard J. Mellanby
DOI: https://doi.org/10.3389/fimmu.2019.00600
IF: 7.3
2019-03-28
Frontiers in Immunology
Abstract:Dendritic cells (DC) are specialized sentinel cells that bridge the innate and adaptive immune response and play a crucial role in shaping the adaptive immune response. Vitamin D, a known epidemiological risk factor for the development of several autoimmune diseases, influences the development of dendritic cells. Consequently, vitamin D metabolites are frequently used in protocols to develop therapeutic dendritic cell therapies for autoimmune diseases. However, the mechanisms by which vitamin D modulates DC function remain poorly understood. We investigated the effects of vitamin D on murine CD11c<sup>+</sup> bone marrow derived DC (BMDC) function by analyzing global gene expression in CD11c<sup>+</sup> BMDC generated in the presence (VitD-CD11c<sup>+</sup>BMDC) or absence (Veh-CD11c<sup>+</sup>BMDC) of the active vitamin D metabolite, 1,25-dihydroxyvitamin D<sub>3</sub> (1,25(OH)<sub>2</sub>D<sub>3</sub>). Seven genes were significantly increased in expression in both immature and LPS-matured VitD-CD11c<sup>+</sup>BMDC, one of which was CD31, a member of the immunoglobulin superfamily. Gene knockdown of CD31 enhanced the ability of VitD-CD11c<sup>+</sup>BMDC to prime naïve CD4<sup>+</sup> T cells <i>in vitro</i>; conversely, increased expression of CD31 on vehicle treated CD11c<sup>+</sup>BMDC restrained their T cell priming abilities. Time-lapse imaging of BMDC and CD4<sup>+</sup> T cells during <i>in vitro</i> priming revealed that CD31 reduced the BMDC–T cell interaction time. Finally, we confirmed a similar effect of 1,25(OH)<sub>2</sub>D<sub>3</sub> on human CD34<sup>+</sup> cell-derived CD11c<sup>+</sup>DC, whereby DC generated in the presence of 1,25(OH)<sub>2</sub>D<sub>3</sub> had increased CD31 expression. In summary, we show that both mouse and human DC generated in the presence of 1,25(OH)<sub>2</sub>D<sub>3</sub> upregulate CD31 expression, resulting in a reduced ability to prime CD4<sup>+</sup> T cells by impairing a stable cell-cell contact.
immunology